Pulmonx LUNG
NASDAQ LUNG
$1.85 -0.13 (-6.57%)
At close: Sep 10, 2026 · 4:00 PM EDT

Pulmonx (LUNG) FCF Margin Growth (3y) (2022 - 2025)

Analysis

Pulmonx (LUNG) FCF Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 884.00
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 503.00
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 646.00
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 534.00
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 919.00
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 3,472.00
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 353.00
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn -97.00
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 60.00
10 Pulmonx 75.94 Mn 6.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4,295.00
Jun 30, 2025 5,444.00
Mar 31, 2025 8,425.00
Dec 31, 2024 5,765.00
Sep 30, 2024 3,741.00
Jun 30, 2024 7,933.00
Mar 31, 2024 4,257.00
Dec 31, 2023 3,526.00
Sep 30, 2023 972.00
Jun 30, 2023 16,489.00
Mar 31, 2023 2,141.00
Dec 31, 2022 -2,871.00